Introduction The majority of patients with coronary heart disease (CHD) are at high sedentary levels, which severely affects patient prognosis and outcome. Despite the proven benefits of reducing ...

Stents and coronary artery bypass grafting (CABG) treat blocked arteries and coronary artery disease (CAD ... widens the diseased blood vessel. Sometimes a stent is permanently inserted to keep the ...

The sdATEV, a 3.5mm vessel, demonstrated sustained patency ... as arteriovenous access for hemodialysis and peripheral artery disease. The company is also expanding into pediatric heart surgery ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a biotechnology company valued at $567 million, has announced its intention to file an Investigational New Drug (IND) application with the U.S. Food and ...

Plans for filing an IND was agreed with the FDA in a recent meeting – – Positive preclinical results of the small-diameter ATEV were recently presented at The American Heart Association’s Scientific ...

to allow first-in-human clinical testing of the small-diameter (3.5mm) acellular tissue engineered vessel (sdATEV) in coronary artery bypass grafting (CABG). The Company’s current plans for ...

In a nutshell Fat hidden between muscle fibers may predict heart problems better than traditional measures like BMI or weight, especially in women. This type of fat can be detected through specialized ...

It found that people with higher amounts of fat stored in their muscles were more likely to have coronary microvascular dysfunction (CMD), a condition that affects the small blood vessels in the ...

This is the first study to comprehensively investigate the effects of fatty muscles on heart disease ... body composition can influence the small blood vessels or ‘microcirculation’ of ...

Coronary artery bypass surgery is a procedure to treat coronary heart disease. There are various ... The procedure involves removing a blood vessel from the chest, arms, or legs and using it ...

A zero calcium score with high cholesterol may mean a person is at a lower risk of coronary ... disease. It means imaging does not show a buildup of calcified plaque in the heart’s blood vessels.

Day two of the J.P Morgan Healthcare Conference rolled on with positive data from Sling Therapeutics Inc. that is leading the company to a phase III study in treating thyroid eye disease. The ...